Patents Prosecuted
Application number | Title of the patent | IPC | Filing Date | Decision Date |
---|---|---|---|---|
18303642 | Compositions and Methods for Diagnosis and Treatment of Cancer | C07K, G01N | Apr 19, 2023 | |
18085206 | MODULAR DRUG PRODUCTION SYSTEM | B01D, G16B, A61K, B01L, B01F | Dec 19, 2022 | |
18049593 | MODIFICATION OF RNA, PRODUCING AN INCREASED TRANSCRIPT STABILITY AND TRANSLATION EFFICIENCY | C12N | Oct 24, 2022 | |
17931215 | METHODS AND COMPOSITIONS FOR STIMULATING IMMUNE RESPONSE | C12N, A61K | Sep 11, 2022 | |
17817033 | MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 | A61K, C07K, G01N | Aug 2, 2022 | |
17688707 | RECOMBINANT VACCINES AND USE THEREOF | A61K, C07K | Mar 6, 2022 | |
17669117 | SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7 | C07D, A61P | Feb 9, 2022 | |
17590550 | SUBSTITUTED IMIDAZOQUINOLINES | A61P, C07D | Jan 31, 2022 | |
17576170 | INDIVIDUALIZED VACCINES FOR CANCER | G16B, A61K, C12Q | Jan 13, 2022 | |
17565842 | RNA constructs and uses thereof | C12N, C12P, A61P, A61K, B82Y | Dec 29, 2021 | Oct 9, 2023 |
17565921 | RNA CONSTRUCTS AND USES THEREOF | A61K, C12N | Dec 29, 2021 | |
18258343 | Therapeutic RNA for Treating Cancer | A61P, A61K | Dec 19, 2021 | |
17539157 | PREDICTING IMMUNOGENICITY OF T CELL EPITOPES | G16B, C12Q, A61K | Nov 29, 2021 | |
18036681 | PHARMACEUTICAL COMPOSITIONS COMPRISING PARTICLES AND MRNA AND METHODS FOR PREPARING AND STORING THE SAME | A61K | Nov 14, 2021 | |
18035172 | MONOCLONAL ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 PROTEIN AND THEIR USE IN MEDICINE | C07K, G01N | Nov 10, 2021 | |
17495571 | METHOD AND SYSTEMS FOR PREDICTION OF HLA CLASS II-SPECIFIC EPITOPES AND CHARACTERIZATION OF CD4+ T CELLS | G16B, A61K, C07K | Oct 5, 2021 | |
17494601 | RNA Replicon for Versatile and Efficient Gene Expression | C12N | Oct 4, 2021 | |
18044955 | AGENTS AND METHODS FOR TARGETED DELIVERY TO CELLS | C12N, A61P, C07K, A61K | Sep 13, 2021 | |
18007096 | RAS NEOANTIGENS AND USES THEREOF | C07K, A61P, C12N, A61K | Aug 11, 2021 | |
18007024 | T CELL MANUFACTURING COMPOSITIONS AND METHODS | C12N, A61K | Aug 11, 2021 |